tiprankstipranks
Trending News
More News >
Fisher & Paykel Healthcare Corporation Limited (FSPKF)
:FSPKF
US Market

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Financial Statements

Compare
54 Followers

Fisher & Paykel Healthcare Corporation Limited Financial Overview

Fisher & Paykel Healthcare Corporation Limited's market cap is currently $12.75B. The company's EPS TTM is $0.222; its P/E ratio is 57.79; and it has a dividend yield of 1.03%. Fisher & Paykel Healthcare Corporation Limited is scheduled to report earnings on May 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue$ 1.28B$ 1.76B$ 1.59B$ 1.64B$ 1.95B
Gross Profit$ 530.20M$ 1.06B$ 945.90M$ 1.01B$ 1.22B
Operating Income$ -371.00M$ 254.40M$ 334.70M$ 509.10M$ 723.20M
EBITDA$ 654.30M$ 368.20M$ 433.70M$ 605.10M$ 808.20M
Net Income$ 377.20M$ 132.60M$ 250.30M$ 376.90M$ 524.20M
Balance Sheet
Cash & Short-Term Investments$ 264.50M$ 82.00M$ 121.00M$ 289.90M$ 377.60M
Total Assets$ 2.55B$ 2.28B$ 2.20B$ 2.11B$ 2.08B
Total Debt$ 153.30M$ 189.10M$ 145.80M$ 104.30M$ 118.40M
Net Debt$ -111.20M$ 107.10M$ 24.80M$ 14.40M$ 21.10M
Total Liabilities$ 660.40M$ 522.60M$ 451.10M$ 427.30M$ 554.10M
Stockholders' Equity$ 1.89B$ 1.76B$ 1.75B$ 1.68B$ 1.52B
Cash Flow
Free Cash Flow$ 445.60M$ 90.60M$ 26.90M$ 154.50M$ 440.60M
Operating Cash Flow$ 548.60M$ 429.60M$ 238.20M$ 324.30M$ 625.30M
Investing Cash Flow$ -103.00M$ -339.00M$ -11.30M$ -89.50M$ -387.30M
Financing Cash Flow$ -268.20M$ -128.70M$ -197.10M$ -235.80M$ -188.00M
Currency in NZD

Fisher & Paykel Healthcare Corporation Limited Earnings and Revenue History

Fisher & Paykel Healthcare Corporation Limited Debt to Assets

Fisher & Paykel Healthcare Corporation Limited Cash Flow

Fisher & Paykel Healthcare Corporation Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis